Related Experiment Video
Updated: Aug 9, 2026

12:26
In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
Published on: June 17, 2019
9.5K
Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming
Jingyi Wang1, Shiling Chen1, Chao Pan1
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in Bioengineering and Biotechnology
|July 25, 2022
Summary
Small molecules can reprogram somatic cells into neurons, offering a new therapeutic strategy for neurological diseases. Further research is needed to optimize this approach for in vivo neural regeneration.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Small Molecule Therapeutics
Background:
- Neurons possess limited regenerative capacity, contributing to poor outcomes in neurological disorders.
- Direct reprogramming of somatic cells into neurons presents a novel therapeutic avenue for treating neurological conditions.
Purpose of the Study:
- To review small molecule-driven neuronal reprogramming strategies for neurological diseases.
- To discuss mechanisms, screening methods, and efficiency detection for small molecule cocktails.
- To collect and analyze studies on neuronal reprogramming in neurological disease models.
Main Methods:
- Review of existing literature on small molecule-mediated neuronal reprogramming.
- Analysis of mechanisms of action for various small molecules.
- Evaluation of screening approaches for small molecule cocktails.
- Examination of methods for assessing reprogramming efficiency.
Main Results:
- Small molecules offer a promising strategy for direct neuronal reprogramming.
- Various small molecules and screening methods have been explored.
- Studies have begun to apply these techniques in neurological disease models.
Conclusions:
- Small molecule-mediated neuronal reprogramming holds potential for neural regeneration in neurological diseases.
- Further investigation into in vivo mechanisms, cocktail optimization, and delivery routes is crucial.
- This approach could lead to new treatments for a range of neurological disorders.
Keywords:
direct neuronal reprogrammingneurological diseaseneuronregeneration medicinesmall moleculetransdifferentiationMore Related Videos
Related Concept Videos
Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.

